Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026
The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.
However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.
“Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020”
On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.
“Penetrating keratoplasty segment accounted for the largest share of artificial cornea and corneal implant market in 2020”
On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.
“North America accounted for the largest share of the artificial cornea and corneal implant market in 2020.”
Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.
Research Coverage:
The market study covers the artificial cornea and corneal implant market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, transplant type, disease indication, end users and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the artificial cornea and corneal implant market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.
However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.
“Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020”
On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.
“Penetrating keratoplasty segment accounted for the largest share of artificial cornea and corneal implant market in 2020”
On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.
“North America accounted for the largest share of the artificial cornea and corneal implant market in 2020.”
Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.
- By Company: Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
- By Designation: C-level Executives: 25%, Directors: 55%, and Others: 20%
- By Region: North America: 40%, Europe: 25%, APAC: 20%, LATAM: 10% and MEA: 5%
Research Coverage:
The market study covers the artificial cornea and corneal implant market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, transplant type, disease indication, end users and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the artificial cornea and corneal implant market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
FIGURE 5 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2021–2026)
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET
4 PREMIUM INSIGHTS
4.1 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET OVERVIEW
FIGURE 12 RISING PREFERENCE OF EYE DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE AND END USER (2020)
FIGURE 13 HUMAN CORNEA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE APAC MARKET IN 2020
4.3 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2021?2026
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE FORECAST PERIOD
4.4 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET:
DEVELOPING VS. DEVELOPED MARKETS
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD
4.5 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 Rapid growth in the geriatric population
FIGURE 17 GERIATRIC POPULATION AS A PERCENTAGE OF THE TOTAL POPULATION, BY REGION, 2017 VS. 2050
5.2.1.2 Rising prevalence of eye diseases
5.2.1.2.1 Corneal blindness
5.2.1.2.2 Cataracts
TABLE 2 TOTAL NUMBER OF CATARACT SURGICAL PROCEDURES PERFORMED, BY COUNTRY, 2017 VS. 2018
5.2.1.2.3 Glaucoma
TABLE 3 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
5.2.1.2.4 Obesity and diabetes
TABLE 4 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2019 VS. 2030 VS. 2045 (MILLION)
5.2.1.3 Increasing government initiatives to control visual impairment
5.2.2 RESTRAINTS
5.2.2.1 High cost of ophthalmology devices and surgical procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Shortage of corneal donors
5.2.3.2 Untapped potential of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Lack of awareness and low access to eye care in low-income economies
5.2.4.2 Shortage of ophthalmologists
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 3D-PRINTED HUMAN CORNEAS
6.2.2 OCT ANGIOGRAPHY DEVICES
6.2.3 ADVANCES IN REFRACTIVE SURGERY
6.3 IMPACT OF COVID-19 ON THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET
6.4 VALUE CHAIN ANALYSIS
FIGURE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS
6.5 ECOSYSTEM
FIGURE 19 ECOSYSTEM: ARTIFICIAL CORNEAL IMPLANTS MARKET (2019)
6.6 REGULATORY ANALYSIS
TABLE 5 STRINGENCY OF REGULATIONS FOR OPHTHALMIC EQUIPMENT, BY REGION
6.6.1 NORTH AMERICA
6.6.1.1 US
TABLE 6 US: CLASSIFICATION OF OPHTHALMIC EQUIPMENT
TABLE 7 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.6.1.2 Canada
TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS
6.6.2 EUROPE
TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS
TABLE 10 EUROPE: CLASSIFICATION OF ARTIFICIAL CORNEAL IMPLANTS ALONG WITH OTHER OPHTHALMIC EQUIPMENT
6.6.3 ASIA PACIFIC
6.6.3.1 Japan
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.6.3.2 China
TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 13 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
7.2 HUMAN CORNEA
7.2.1 INCREASING PREVALENCE OF CORNEAL BLINDNESS TO DRIVE MARKET GROWTH
TABLE 14 US: TOTAL DONATIONS AND DISTRIBUTION OF TISSUE, 2019
FIGURE 20 US: CORNEAL TRANSPLANT SUPPLIED BY EYE BANKS, 2010?2019
TABLE 15 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HUMAN CORNEA, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 ARTIFICIAL CORNEA
7.3.1 SCARCITY OF HUMAN EYE DONORS HAS PROPELLED MARKET GROWTH
TABLE 16 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ARTIFICIAL CORNEA, BY COUNTRY, 2019–2026 (USD MILLION)
8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE
8.1 INTRODUCTION
TABLE 17 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
FIGURE 21 US: SURGERY TRENDS, 2010?2019
8.2 PENETRATING KERATOPLASTY
8.2.1 PK ENABLES THE ABILITY TO TREAT KERATITIS AND INJURY OF THE EYEBALL
TABLE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 ENDOTHELIAL KERATOPLASTY
8.3.1 ADVANTAGES SUCH AS FASTER VISUAL RECOVERY AND LESS PRONE TO INJURY ARE SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 19 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 OTHER TRANSPLANTS
TABLE 20 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER TRANSPLANTS, BY COUNTRY, 2019–2026 (USD MILLION)
9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION
9.1 INTRODUCTION
TABLE 21 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
9.2 FUCHS’ DYSTROPHY
9.2.1 RISING PREVALENCE OF FUCHS’ DYSTROPHY IS THE KEY FACTOR DRIVING MARKET GROWTH
TABLE 22 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUCHS’ DYSTROPHY, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 FUNGAL KERATITIS
9.3.1 LARGE PATIENT POPULATION SUFFERING FROM FUNGUS KERATITIS TO DRIVE MARKET GROWTH
TABLE 23 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS, BY REGION (2019)
TABLE 24 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 KERATOCONUS
9.4.1 INCREASING RESEARCH ON KERATOCONUS TREATMENT TO SUPPORT MARKET GROWTH
TABLE 25 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY, 2019–2026 (USD MILLION)
9.5 OTHER DISEASES
TABLE 26 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 27 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 IMPACT OF COVID-19 ON THE END-USER MARKET
10.3 HOSPITALS
10.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS ARE THE KEY FACTORS DRIVING MARKET GROWTH
TABLE 28 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS
10.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE HAS RESULTED IN GROWING END-USER INTEREST TOWARDS ASCS
TABLE 29 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
11 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 30 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
TABLE 32 EYE BANKING STATISTICS IN NORTH AMERICA REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
FIGURE 22 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the artificial cornea and corneal implants market
FIGURE 23 EYE BANKING STATISTICS IN THE US: AVERAGE CORNEAS RECOVERED FOR TRANSPLANT (2011-2019)
TABLE 38 US: KEY MACROINDICATORS
TABLE 39 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 40 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 41 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 42 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing number of cataract and diabetic retinopathy cases to propel market growth
TABLE 43 CANADA: KEY MACROINDICATORS
TABLE 44 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 46 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 47 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
TABLE 48 EYE BANKING STATISTICS IN EUROPE REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
TABLE 49 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 50 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 52 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 53 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Established healthcare infrastructure and higher healthcare spending to drive the market growth
TABLE 54 GERMANY: KEY MACROINDICATORS
TABLE 55 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 57 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 58 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 UK
11.3.2.1 Rising prevalence of diabetes and related eye diseases to support market growth
FIGURE 24 UK: NUMBER OF CORNEAS RETRIEVED TO NHSBT EYE BANKS AND CORNEAS GRAFTED
FIGURE 25 UK: NUMBER OF CORNEAL TRANSPLANTS, BY INDICATION, 2010?2020
TABLE 59 UK: KEY MACROINDICATORS
TABLE 60 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 62 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 63 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Growing awareness of eye health to drive the market growth in France
TABLE 64 FRANCE: KEY MACROINDICATORS
TABLE 65 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 67 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 68 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 REST OF EUROPE
FIGURE 26 ITALY: NUMBER OF CORNEA DONATIONS, 2014-2019
TABLE 69 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 71 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 72 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 73 EYE BANKING STATISTICS IN THE ASIA PACIFIC REPORTED
BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
FIGURE 27 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
TABLE 74 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 75 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 77 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 China to register the highest growth rate in the artificial cornea and corneal implants market
TABLE 79 CHINA: KEY MACROINDICATORS
TABLE 80 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 82 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 83 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Large geriatric population in the country to support market growth
TABLE 84 JAPAN: KEY MACROINDICATORS
TABLE 85 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 87 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 88 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 REST OF ASIA PACIFIC
TABLE 89 INDIA: NUMBER OF DONATED EYES FOR CORNEAL TRANSPLANTATION
TABLE 90 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 92 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 93 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT VISION CARE TO SUPPORT MARKET GROWTH
TABLE 94 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS IN LATIN AMERICA
FIGURE 28 NUMBER OF CORNEA TRANSPLANTS PERFORMED IN BRAZIL AND MEXICO FROM 2010 TO 2019 (THOUSAND)
TABLE 95 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 97 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 98 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING MEDICAL TOURISM IS THE KEY GROWTH DRIVER FOR THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE MEA
TABLE 99 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
FIGURE 29 KEY DEVELOPMENTS IN THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FROM JANUARY 2018 TO DECEMBER 2020
FIGURE 30 MARKET EVALUATION FRAMEWORK: OTHER DEVELOPMENTS WAS THE MOST WIDELY ADOPTED STRATEGY BETWEEN 2018 & 2020
12.2 ARTIFICIAL CORNEA MARKET RANKING
12.3 HUMAN CORNEA MARKET RANKING
12.4 PRODUCT BENCHMARKING
FIGURE 31 PRODUCT PORTFOLIO ANALYSIS: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
12.5 COMPETITIVE SITUATIONS & TRENDS
12.5.1 PRODUCT LAUNCHES & APPROVALS
12.5.2 ACQUISITIONS
12.5.3 EXPANSIONS
12.5.4 OTHER DEVELOPMENTS
13 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY AND COMPANY PROFILES
13.1 COMPETITIVE LEADERSHIP MAPPING
13.1.1 STARS
13.1.2 EMERGING LEADERS
13.1.3 PERVASIVE COMPANIES
13.1.4 EMERGING COMPANIES
FIGURE 32 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
13.2 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
13.2.1 PROGRESSIVE COMPANIES
13.2.2 DYNAMIC COMPANIES
13.2.3 STARTING BLOCKS
13.2.4 RESPONSIVE COMPANIES
FIGURE 33 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: STARTUP COMPANY EVALUATION MATRIX (2020)
13.3 COMPANY PROFILES
(Business overview, Products offered, Recent developments)*
13.3.1 AJL OPHTHALMIC S.A.
13.3.2 CORNEAGEN, INC.
13.3.3 ADDITION TECHNOLOGY, INC.
13.3.4 LINKOCARE LIFE SCIENCES AB
13.3.5 PRESBIA PLC
FIGURE 34 PRESBIA PLC: COMPANY SNAPSHOT (2018)
13.3.6 MEDIPHACOS
13.3.7 AUROLAB
13.3.8 CORNEA BIOSCIENCES, INC.
13.3.9 DIOPTEX MEDIZINPRODUKTE FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DIOPTEX GMBH)
13.3.10 EYEYON MEDICAL
13.3.11 MASSACHUSETTS EYE AND EAR
FIGURE 35 MASSACHUSETTS EYE AND EAR: COMPANY SNAPSHOT (2020)
13.3.12 FLORIDA LIONS EYE BANK
FIGURE 36 FLORIDA LIONS EYE BANK: COMPANY SNAPSHOT (2019)
13.3.13 SIGHTLIFE
FIGURE 37 SIGHTLIFE: COMPANY SNAPSHOT (2019)
13.3.14 ADVANCING SIGHT NETWORK
13.3.15 SAN DIEGO EYE BANK
13.3.16 L V PRASAD EYE INSTITUTE
13.3.17 NEW MEXICO LIONS EYE BANK
13.3.18 SAN ANTONIO EYE BANK
13.3.19 KANSAS EYE BANK & CORNEA RESEARCH CENTER
13.3.20 ROCKY MOUNTAIN LIONS EYE BANK
13.3.21 CORNEAT VISION
13.3.22 KERAMED, INC.
*Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
FIGURE 5 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2021–2026)
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET
4 PREMIUM INSIGHTS
4.1 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET OVERVIEW
FIGURE 12 RISING PREFERENCE OF EYE DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE AND END USER (2020)
FIGURE 13 HUMAN CORNEA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE APAC MARKET IN 2020
4.3 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2021?2026
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE FORECAST PERIOD
4.4 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET:
DEVELOPING VS. DEVELOPED MARKETS
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD
4.5 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 Rapid growth in the geriatric population
FIGURE 17 GERIATRIC POPULATION AS A PERCENTAGE OF THE TOTAL POPULATION, BY REGION, 2017 VS. 2050
5.2.1.2 Rising prevalence of eye diseases
5.2.1.2.1 Corneal blindness
5.2.1.2.2 Cataracts
TABLE 2 TOTAL NUMBER OF CATARACT SURGICAL PROCEDURES PERFORMED, BY COUNTRY, 2017 VS. 2018
5.2.1.2.3 Glaucoma
TABLE 3 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
5.2.1.2.4 Obesity and diabetes
TABLE 4 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2019 VS. 2030 VS. 2045 (MILLION)
5.2.1.3 Increasing government initiatives to control visual impairment
5.2.2 RESTRAINTS
5.2.2.1 High cost of ophthalmology devices and surgical procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Shortage of corneal donors
5.2.3.2 Untapped potential of emerging markets
5.2.4 CHALLENGES
5.2.4.1 Lack of awareness and low access to eye care in low-income economies
5.2.4.2 Shortage of ophthalmologists
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 3D-PRINTED HUMAN CORNEAS
6.2.2 OCT ANGIOGRAPHY DEVICES
6.2.3 ADVANCES IN REFRACTIVE SURGERY
6.3 IMPACT OF COVID-19 ON THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET
6.4 VALUE CHAIN ANALYSIS
FIGURE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS
6.5 ECOSYSTEM
FIGURE 19 ECOSYSTEM: ARTIFICIAL CORNEAL IMPLANTS MARKET (2019)
6.6 REGULATORY ANALYSIS
TABLE 5 STRINGENCY OF REGULATIONS FOR OPHTHALMIC EQUIPMENT, BY REGION
6.6.1 NORTH AMERICA
6.6.1.1 US
TABLE 6 US: CLASSIFICATION OF OPHTHALMIC EQUIPMENT
TABLE 7 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.6.1.2 Canada
TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS
6.6.2 EUROPE
TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF
THE REGISTRATION PROCESS
TABLE 10 EUROPE: CLASSIFICATION OF ARTIFICIAL CORNEAL IMPLANTS ALONG WITH OTHER OPHTHALMIC EQUIPMENT
6.6.3 ASIA PACIFIC
6.6.3.1 Japan
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
6.6.3.2 China
TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
7 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 13 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
7.2 HUMAN CORNEA
7.2.1 INCREASING PREVALENCE OF CORNEAL BLINDNESS TO DRIVE MARKET GROWTH
TABLE 14 US: TOTAL DONATIONS AND DISTRIBUTION OF TISSUE, 2019
FIGURE 20 US: CORNEAL TRANSPLANT SUPPLIED BY EYE BANKS, 2010?2019
TABLE 15 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HUMAN CORNEA, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 ARTIFICIAL CORNEA
7.3.1 SCARCITY OF HUMAN EYE DONORS HAS PROPELLED MARKET GROWTH
TABLE 16 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ARTIFICIAL CORNEA, BY COUNTRY, 2019–2026 (USD MILLION)
8 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE
8.1 INTRODUCTION
TABLE 17 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
FIGURE 21 US: SURGERY TRENDS, 2010?2019
8.2 PENETRATING KERATOPLASTY
8.2.1 PK ENABLES THE ABILITY TO TREAT KERATITIS AND INJURY OF THE EYEBALL
TABLE 18 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 ENDOTHELIAL KERATOPLASTY
8.3.1 ADVANTAGES SUCH AS FASTER VISUAL RECOVERY AND LESS PRONE TO INJURY ARE SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 19 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 OTHER TRANSPLANTS
TABLE 20 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER TRANSPLANTS, BY COUNTRY, 2019–2026 (USD MILLION)
9 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION
9.1 INTRODUCTION
TABLE 21 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
9.2 FUCHS’ DYSTROPHY
9.2.1 RISING PREVALENCE OF FUCHS’ DYSTROPHY IS THE KEY FACTOR DRIVING MARKET GROWTH
TABLE 22 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUCHS’ DYSTROPHY, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 FUNGAL KERATITIS
9.3.1 LARGE PATIENT POPULATION SUFFERING FROM FUNGUS KERATITIS TO DRIVE MARKET GROWTH
TABLE 23 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS, BY REGION (2019)
TABLE 24 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 KERATOCONUS
9.4.1 INCREASING RESEARCH ON KERATOCONUS TREATMENT TO SUPPORT MARKET GROWTH
TABLE 25 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY, 2019–2026 (USD MILLION)
9.5 OTHER DISEASES
TABLE 26 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
10 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 27 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 IMPACT OF COVID-19 ON THE END-USER MARKET
10.3 HOSPITALS
10.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS ARE THE KEY FACTORS DRIVING MARKET GROWTH
TABLE 28 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS
10.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE HAS RESULTED IN GROWING END-USER INTEREST TOWARDS ASCS
TABLE 29 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
11 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 30 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
TABLE 32 EYE BANKING STATISTICS IN NORTH AMERICA REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
FIGURE 22 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the artificial cornea and corneal implants market
FIGURE 23 EYE BANKING STATISTICS IN THE US: AVERAGE CORNEAS RECOVERED FOR TRANSPLANT (2011-2019)
TABLE 38 US: KEY MACROINDICATORS
TABLE 39 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 40 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 41 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 42 US: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing number of cataract and diabetic retinopathy cases to propel market growth
TABLE 43 CANADA: KEY MACROINDICATORS
TABLE 44 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 46 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 47 CANADA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
TABLE 48 EYE BANKING STATISTICS IN EUROPE REPORTED BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
TABLE 49 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 50 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 52 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 53 EUROPE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Established healthcare infrastructure and higher healthcare spending to drive the market growth
TABLE 54 GERMANY: KEY MACROINDICATORS
TABLE 55 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 57 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 58 GERMANY: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 UK
11.3.2.1 Rising prevalence of diabetes and related eye diseases to support market growth
FIGURE 24 UK: NUMBER OF CORNEAS RETRIEVED TO NHSBT EYE BANKS AND CORNEAS GRAFTED
FIGURE 25 UK: NUMBER OF CORNEAL TRANSPLANTS, BY INDICATION, 2010?2020
TABLE 59 UK: KEY MACROINDICATORS
TABLE 60 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 62 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 63 UK: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Growing awareness of eye health to drive the market growth in France
TABLE 64 FRANCE: KEY MACROINDICATORS
TABLE 65 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 67 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 68 FRANCE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 REST OF EUROPE
FIGURE 26 ITALY: NUMBER OF CORNEA DONATIONS, 2014-2019
TABLE 69 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 71 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 72 ROE: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 73 EYE BANKING STATISTICS IN THE ASIA PACIFIC REPORTED
BY EBAA MEMBERS: COUNTRIES OF DESTINATION (2019)
FIGURE 27 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET SNAPSHOT
TABLE 74 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 75 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 77 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 China to register the highest growth rate in the artificial cornea and corneal implants market
TABLE 79 CHINA: KEY MACROINDICATORS
TABLE 80 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 82 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 83 CHINA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Large geriatric population in the country to support market growth
TABLE 84 JAPAN: KEY MACROINDICATORS
TABLE 85 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 87 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 88 JAPAN: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 REST OF ASIA PACIFIC
TABLE 89 INDIA: NUMBER OF DONATED EYES FOR CORNEAL TRANSPLANTATION
TABLE 90 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 92 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 93 ROAPAC: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT VISION CARE TO SUPPORT MARKET GROWTH
TABLE 94 ESTIMATED ANNUAL INCIDENCE OF FUNGAL KERATITIS IN LATIN AMERICA
FIGURE 28 NUMBER OF CORNEA TRANSPLANTS PERFORMED IN BRAZIL AND MEXICO FROM 2010 TO 2019 (THOUSAND)
TABLE 95 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 97 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 98 LATIN AMERICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING MEDICAL TOURISM IS THE KEY GROWTH DRIVER FOR THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET IN THE MEA
TABLE 99 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY TRANSPLANT TYPE, 2019–2026 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY DISEASE INDICATION, 2019–2026 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET, BY END USER, 2019–2026 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
FIGURE 29 KEY DEVELOPMENTS IN THE ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET FROM JANUARY 2018 TO DECEMBER 2020
FIGURE 30 MARKET EVALUATION FRAMEWORK: OTHER DEVELOPMENTS WAS THE MOST WIDELY ADOPTED STRATEGY BETWEEN 2018 & 2020
12.2 ARTIFICIAL CORNEA MARKET RANKING
12.3 HUMAN CORNEA MARKET RANKING
12.4 PRODUCT BENCHMARKING
FIGURE 31 PRODUCT PORTFOLIO ANALYSIS: ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET (2020)
12.5 COMPETITIVE SITUATIONS & TRENDS
12.5.1 PRODUCT LAUNCHES & APPROVALS
12.5.2 ACQUISITIONS
12.5.3 EXPANSIONS
12.5.4 OTHER DEVELOPMENTS
13 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY AND COMPANY PROFILES
13.1 COMPETITIVE LEADERSHIP MAPPING
13.1.1 STARS
13.1.2 EMERGING LEADERS
13.1.3 PERVASIVE COMPANIES
13.1.4 EMERGING COMPANIES
FIGURE 32 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
13.2 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
13.2.1 PROGRESSIVE COMPANIES
13.2.2 DYNAMIC COMPANIES
13.2.3 STARTING BLOCKS
13.2.4 RESPONSIVE COMPANIES
FIGURE 33 ARTIFICIAL CORNEA AND CORNEAL IMPLANTS MARKET: STARTUP COMPANY EVALUATION MATRIX (2020)
13.3 COMPANY PROFILES
(Business overview, Products offered, Recent developments)*
13.3.1 AJL OPHTHALMIC S.A.
13.3.2 CORNEAGEN, INC.
13.3.3 ADDITION TECHNOLOGY, INC.
13.3.4 LINKOCARE LIFE SCIENCES AB
13.3.5 PRESBIA PLC
FIGURE 34 PRESBIA PLC: COMPANY SNAPSHOT (2018)
13.3.6 MEDIPHACOS
13.3.7 AUROLAB
13.3.8 CORNEA BIOSCIENCES, INC.
13.3.9 DIOPTEX MEDIZINPRODUKTE FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DIOPTEX GMBH)
13.3.10 EYEYON MEDICAL
13.3.11 MASSACHUSETTS EYE AND EAR
FIGURE 35 MASSACHUSETTS EYE AND EAR: COMPANY SNAPSHOT (2020)
13.3.12 FLORIDA LIONS EYE BANK
FIGURE 36 FLORIDA LIONS EYE BANK: COMPANY SNAPSHOT (2019)
13.3.13 SIGHTLIFE
FIGURE 37 SIGHTLIFE: COMPANY SNAPSHOT (2019)
13.3.14 ADVANCING SIGHT NETWORK
13.3.15 SAN DIEGO EYE BANK
13.3.16 L V PRASAD EYE INSTITUTE
13.3.17 NEW MEXICO LIONS EYE BANK
13.3.18 SAN ANTONIO EYE BANK
13.3.19 KANSAS EYE BANK & CORNEA RESEARCH CENTER
13.3.20 ROCKY MOUNTAIN LIONS EYE BANK
13.3.21 CORNEAT VISION
13.3.22 KERAMED, INC.
*Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 AUTHOR DETAILS
